Denosumab: In the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumours

Author： Scott Lesley J. Muir Victoria J.

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.8, 2011-05, pp. : 1059-1069

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours

By Gibiansky Leonid

Clinical Pharmacokinetics, Vol. 51, Iss. 4, 2012-04 ,pp. : 247-260

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of Bisphosphonates for Skeletal-Related Event Prevention in Metastatic Non-Breast Solid Tumours

By Carter John A.

PharmacoEconomics, Vol. 30, Iss. 5, 2012-05 ,pp. : 373-386

Adis International

Access to resources Recommend Favorite

Clodronate: A Review of its Use in the Prevention of Bone Metastases and the Management of Skeletal Complications Associated with Bone Metastases in Patients with Breast Cancer

By Toni M. Dando Lynda R. Wiseman

Drugs & Aging, Vol. 21, Iss. 14, 2004-01 ,pp. : 949-962

Adis International

Access to resources Recommend Favorite

Temozolomide plus whole-brain irradiation (WBI) is effective for patients with brain metastases from various solid tumours

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Prevention and Treatment of Bone Metastases

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-09 ,pp. : 2998-3006

Bentham Science Publishers

Access to resources Recommend Favorite